tiprankstipranks
Teva Pharmaceutical Industries Limited (TEVA)
:TEVA
US Market

Teva Pharmaceutical (TEVA) Income Statement

Compare
7,056 Followers

Teva Pharmaceutical Income Statement

Last quarter (Q4 2024), Teva Pharmaceutical's total revenue was $4.23B, a decrease of -5.12% from the same quarter last year. In Q4, Teva Pharmaceutical's net income was $-217.00M. See Teva Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 16.54B$ 15.85B$ 14.93B$ 15.88B$ 16.66B
Gross Profit
$ 8.06B$ 7.65B$ 6.97B$ 7.59B$ 7.72B
Operating Expenses
$ 8.37B$ 7.21B$ 4.28B$ 4.50B$ 4.67B
Depreciation and Amortization
$ 0.00$ 1.15B$ 1.31B$ 1.33B$ 1.56B
EBITDA
$ -303.00M$ 1.57B$ -874.00M$ 4.41B$ -2.09B
Operating Income
$ -303.00M$ 433.00M$ 2.80B$ 3.20B$ 3.05B
Other Income/Expenses
$ -981.00M$ -1.06B$ -1.06B$ -1.06B$ -834.00M
Pretax Income
$ -1.28B$ -624.00M$ -3.06B$ 658.00M$ -4.41B
Net Income
$ -1.64B$ -559.00M$ -2.35B$ 417.00M$ -3.99B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.45$ -0.50$ -2.12$ 0.38$ -3.64
Diluted EPS
$ -1.45$ -0.50$ -2.12$ 0.38$ -3.64
Weighted Average Shares Outstanding
1.13B 1.12B 1.11B 1.10B 1.09B
Weighted Average Shares Outstanding (Diluted)
1.13B 1.12B 1.11B 1.11B 1.09B
Currency in USD

Teva Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis